| |
| Narcotics, benzodiazepines, stimulants, and gabapentin: policies, initiatives, and practices across Canada, 2014 |
| CADTH |
|
|
| |
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Narcotics, benzodiazepines, stimulants, and gabapentin: policies, initiatives, and practices across Canada, 2014. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Environmental Scans; issue 45. 2014 Authors' conclusions The survey of Canada's publicly funded drug plans, colleges of physicians and surgeons, and colleges of pharmacists shows that jurisdictions have established multiple avenues to address the issue of prescription drug abuse. Indexing Status Subject indexing assigned by CRD MeSH Benzodiazepines; Canada; Central Nervous System Stimulants; Cyclohexanecarboxylic Acids; Humans; Narcotics; gamma-Aminobutyric Acid Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32015000148 Date abstract record published 04/03/2015 |
| |
|
|
